Advertisement

Healthcare disparities in Asians and Pacific Islanders with hepatocellular cancer

Published:January 09, 2012DOI:https://doi.org/10.1016/j.amjsurg.2011.06.055

      Abstract

      Background

      Hawaii has the highest incidence of hepatocellular cancer (HCC) in the United States and the largest proportion of Asians and Pacific Islanders. HCC studies generally combine these groups into 1 ethnicity, and we sought to examine differences between Asian and Pacific Islander subpopulations.

      Methods

      Demographic, clinical, and treatment data for 617 patients with HCC (420 Asians, 114 whites, and 83 Pacific Islanders) were reviewed. Main outcome measures included HCC screening and liver transplantation.

      Results

      Asian and Pacific Islander subgroups had significantly more immigrants, and age was different between groups. Compared with whites, Pacific Islanders and Filipinos had less HCC screening and liver transplantation procedures, fewer met Milan criteria, and a smaller proportion of those with Milan criteria actually underwent transplantation.

      Conclusions

      There were significant differences in risk factors, clinical presentation, treatment, and access to care among Asian, Pacific Islander, and white patients with HCC. Future HCC studies may benefit from differentiating subgroups within Asian and Pacific Islander populations to better focus these efforts.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Global Health Observatory Data Repository at World Health Organization.
        (Accessed September 1, 2010)
        • National Cancer Institute
        Cancer statistics.
        (Accessed October 1, 2010)
        • Lin S.Y.
        • Chang E.T.
        • So S.K.
        Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California.
        Hepatology. 2007; 46: 1034-1040
        • Hagan H.
        • Campbell J.
        • Thiede H.
        • et al.
        Self reported hepatitis C virus antibody status and risk behavior in young injectors.
        Public Health Rep. 2006; 121: 710-719
        • US Census Bureau
        Fact sheet: Hawaii.
        (Accessed September 1, 2010)
        • Tsai N.
        • Holck P.S.
        • Wong L.L.
        • et al.
        Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii.
        Hepatol Int. 2008; 2: 478-485
        • United Network for Organ Sharing
        Policy 3.6.4.4.
        (Accessed May 20, 2009)
        • Edge S.B.
        • Byrd D.R.
        • Compton C.C.
        • et al.
        AJCC cancer staging manual.
        in: 7th ed. Springer, New York2009: 191-199
        • Hawaiians, Pacific Islanders tallied
        Honolulu Star Bulletin, March 13, 2001: 1
        • Intercultural Cancer Council
        Native Hawaiians and Pacific Islanders & cancer.
        (Accessed November 1, 2010)
        • Chu K.C.
        Cancer data for Asian Americans and Pacific Islanders.
        Asian Am Pacific Islander J Health. 1998; 6: 130-139
        • Artinyan A.
        • Mailey B.
        • Sanchez-Luege N.
        • et al.
        Race, ethnicity and socioeconomic statutes influence the survival of patients with hepatocellular carcinoma in the United States.
        Cancer. 2010; 116: 1367-1377
        • Davilla J.A.
        • El-Serag H.B.
        Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.
        Clin Gastroenterol Hepatol. 2006; 4: 104-110
        • Yu J.C.
        • Neugut A.I.
        • Wang S.
        • et al.
        Racial and insurance disparities in the receipt of transplant among patients with hepatocellular cancer.
        Cancer. 2010; 116: 1801-1809
        • Siegel A.B.
        • McBride R.B.
        • El-Serag H.B.
        • et al.
        Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States 1998-2002.
        Am J Gastroenterol. 2008; 103: 120-127
        • Wong L.L.
        • Tsai N.
        • Limm W.
        • et al.
        Liver transplant for hepatocellular cancer: a treatment for the select few.
        Clin Transplant. 2004; 18: 205-210
        • US Department of Health and Human Services
        OPTN/SRTR annual report 2009: transplant data 1998-2008.
        (Accessed November 9, 2010)
        • Ghosh C.
        A national health agenda for Asian Americans and Pacific Islanders.
        JAMA. 2010; 304: 1381-1382